Haddad 2011.
| Study characteristics | ||
| Methods | Study design: RCT Number randomized: 163; 53 to the yoga exercise group, 56 to the stretching exercise group, and 54 to the control group Study start and stop dates: not reported Length of intervention: 6 weeks Length of follow‐up: 1, 3, and 6 months |
|
| Participants | Type cancer: breast cancer, Stages 0 to III Time since cancer diagnosis: not reported Time in active treatment: not reported Inclusion criteria:
Eligibility criteria related to interest or ability, or both, to exercise:
Exclusion criteria:
Gender: female Current age, mean years: 51.9 years Age at cancer diagnosis: not reported Ethnicity/race: not reported Education level: not reported SES: not reported Employment status: not reported Comorbidities: not reported Past exercise history: not reported On hormone therapy: not reported |
|
| Interventions | 53 participants assigned to the yoga exercise intervention 56 participants assigned to the stretching exercise intervention Type exercise (aerobic/anaerobic): aerobic or anaerobic
Intensity of the experimental exercise intervention: not reported Frequency: 3 times per week for either yoga or stretching Duration of individual sessions: not reported Duration of exercise program: 6 weeks Total number of exercise sessions: 18 sessions for either yoga or stretching Format: not reported Facility: unclear Professionally led: not reported Adherence: not reported 54 participants assigned to control group, including:
Contamination of control group: not reported |
|
| Outcomes | No primary outcome was identified. QoL outcomes included:
Outcomes were measured at baseline, end of treatment (6 weeks), 1, 3, and 6 months following end of treatment:
Subgroup analysis: not reported Adverse events: not reported |
|
| Notes | Country: unclear, investigators from US, India and Germany Funding: none reported Published conference abstract |
|
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Generation of allocation sequence was not described |
| Allocation concealment (selection bias) | Unclear risk | Whether the treatment assignment was concealed from study personnel and participants was not described |
| Blinding of participants and personnel (performance bias) All outcomes | High risk | Owing to the nature of the intervention, it was not possible to conceal allocation to the intervention from the participants |
| Blinding of outcome assessment (detection bias) All outcomes | High risk | Study personnel and outcome assessors were not masked or blinded to the study interventions |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Insufficient details provided to determine whether there was any attrition |
| Selective reporting (reporting bias) | Unclear risk | Insufficient details provided to assess whether there was selective outcome reporting |
| Other bias | Low risk | The trial appears to be free of other problems that could put it at a high risk of bias |